These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30604891)

  • 21. Beyond "Triton": Malignant Peripheral Nerve Sheath Tumors With Complete Heterologous Rhabdomyoblastic Differentiation Mimicking Spindle Cell Rhabdomyosarcoma.
    Hornick JL; Nielsen GP
    Am J Surg Pathol; 2019 Oct; 43(10):1323-1330. PubMed ID: 31107719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylation profiling reveals novel molecular classes of rhabdomyosarcoma.
    Clay MR; Patel A; Tran Q; Hedges DJ; Chang TC; Stewart E; Charville G; Cline C; Dyer MA; Orr BA
    Sci Rep; 2021 Nov; 11(1):22213. PubMed ID: 34782706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Congenital spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological analysis].
    Xu JT; Fu LB; Yao XF; Jia C; Guan XX; Zhang M; He LJ
    Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):344-350. PubMed ID: 38556817
    [No Abstract]   [Full Text] [Related]  

  • 24. Myogenin--a more specific target for RT-PCR detection of rhabdomyosarcoma than MyoD1.
    Michelagnoli MP; Burchill SA; Cullinane C; Selby PJ; Lewis IJ
    Med Pediatr Oncol; 2003 Jan; 40(1):1-8. PubMed ID: 12426678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment and characterization of NCC-ssRMS2-C1: a novel patient-derived cell line of spindle cell/sclerosing rhabdomyosarcoma.
    Tsuchiya R; Yoshimatsu Y; Noguchi R; Sin Y; Ono T; Sei A; Takeshita F; Sugaya J; Nakatani F; Yoshida A; Ohtori S; Kawai A; Kondo T
    Hum Cell; 2021 Sep; 34(5):1569-1578. PubMed ID: 34164773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rhabdomyosarcoma in middle to old-aged patients: analysis of clinicopathological features and prognosis in 76 cases].
    Yu L; Wang J
    Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):910-6. PubMed ID: 23336377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment and Characterization of a Sclerosing Spindle Cell Rhabdomyosarcoma Cell Line with a Complex Genomic Profile.
    Schleicher S; Grote S; Malenke E; Chan KC; Schaller M; Fehrenbacher B; Riester R; Kluba T; Frauenfeld L; Boesmueller H; Göhring G; Schlegelberger B; Handgretinger R; Kopp HG; Traub F; Boehme KA
    Cells; 2020 Dec; 9(12):. PubMed ID: 33322555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinicopathologic features of pleomorphic rhabdomyosarcoma].
    Yu L; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):147-52. PubMed ID: 23769431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolving classification of rhabdomyosarcoma.
    Agaram NP
    Histopathology; 2022 Jan; 80(1):98-108. PubMed ID: 34958505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sclerosing rhabdomyosarcoma in childhood: case report and review of the literature.
    Vadgama B; Sebire NJ; Malone M; Ramsay AD
    Pediatr Dev Pathol; 2004; 7(4):391-6. PubMed ID: 15383934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers.
    Furlong MA; Mentzel T; Fanburg-Smith JC
    Mod Pathol; 2001 Jun; 14(6):595-603. PubMed ID: 11406662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spindle cell rhabdomyosarcomas: With TFCP2 rearrangements, and novel EWSR1::ZBTB41 and PLOD2::RBM6 gene fusions. A study of five cases and review of the literature.
    Bradová M; Mosaieby E; Michal M; Vaněček T; Ing SK; Grossmann P; Koshyk O; Kinkor Z; Laciok Š; Nemcová A; Straka Ľ; Farkas M; Michal M; Švajdler M
    Histopathology; 2024 Apr; 84(5):776-793. PubMed ID: 38114270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sclerosing rhabdomyosarcoma: a clinicopathologic study of four cases with review of literature].
    Zhu L; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):587-91. PubMed ID: 18070445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations.
    Kohsaka S; Shukla N; Ameur N; Ito T; Ng CK; Wang L; Lim D; Marchetti A; Viale A; Pirun M; Socci ND; Qin LX; Sciot R; Bridge J; Singer S; Meyers P; Wexler LH; Barr FG; Dogan S; Fletcher JA; Reis-Filho JS; Ladanyi M
    Nat Genet; 2014 Jun; 46(6):595-600. PubMed ID: 24793135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soft Tissue Special Issue: Skeletal Muscle Tumors: A Clinicopathological Review.
    Kohashi K; Kinoshita I; Oda Y
    Head Neck Pathol; 2020 Mar; 14(1):12-20. PubMed ID: 31950473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group.
    Chiles MC; Parham DM; Qualman SJ; Teot LA; Bridge JA; Ullrich F; Barr FG; Meyer WH;
    Pediatr Dev Pathol; 2004; 7(6):583-94. PubMed ID: 15630526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new human pleomorphic rhabdomyosarcoma cell-line, HS-RMS-1, exhibiting MyoD1 and myogenin.
    Sonobe H; Takeuchi T; Taguchi T; Shimizu K; Furihata M; Ohtsuki Y
    Int J Oncol; 2000 Jul; 17(1):119-25. PubMed ID: 10853028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases.
    Xu B; Suurmeijer AJH; Agaram NP; Zhang L; Antonescu CR
    Histopathology; 2021 Sep; 79(3):347-357. PubMed ID: 33382123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of primary spindle cell variant of embryonal rhabdomyosarcoma of the prostate.
    Asahina M; Saito T; Arakawa A; Suehara Y; Takagi T; Hisasue S; Kaneko K; Horie S; Yao T
    Int J Clin Exp Pathol; 2014; 7(8):5181-5. PubMed ID: 25197394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylation alterations of the MyoD1 upstream region are predictive of subclassification of human rhabdomyosarcomas.
    Chen B; Dias P; Jenkins JJ; Savell VH; Parham DM
    Am J Pathol; 1998 Apr; 152(4):1071-9. PubMed ID: 9546368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.